{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:03:39Z","timestamp":1782230619178,"version":"3.54.5"},"reference-count":34,"publisher":"Baishideng Publishing Group Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.1237","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T09:05:00Z","timestamp":1204189500000},"page":"1237","source":"Crossref","is-referenced-by-count":45,"title":["Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006"],"prefix":"10.3748","volume":"14","author":[{"given":"Francois","family":"Roman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hawotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Struck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Ternes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Servais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vic","family":"Arendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Staub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Seguin-Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Schmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45:529-538.","DOI":"10.1016\/j.jhep.2006.05.013"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973.","DOI":"10.1002\/hep.20819"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol 1997;78:321-328.","DOI":"10.1099\/0022-1317-78-2-321"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.","DOI":"10.1099\/0022-1317-74-11-2391"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339:1485-1492.","DOI":"10.1056\/NEJM199811193392101"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 1998;352:1426-1432.","DOI":"10.1016\/S0140-6736(98)07124-4"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Pawlotsky JM. Treating hepatitis C in &ldquo;difficult-to-treat&rdquo; patients. N Engl J Med 2004;351:422-423.","DOI":"10.1056\/NEJMp048068"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-567.","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, Strauss S. Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 2007;89:1-12.","DOI":"10.1016\/j.drugalcdep.2006.11.014"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1\/2, HTLV-I\/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 2000;33:27-30.","DOI":"10.1590\/S0037-86822000000100004"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Heimberger TS, Chang HG, Birkhead GS, DiFerdinando GD, Greenberg AJ, Gunn R, Morse DL. High prevalence of syphilis detected through a jail screening program. A potential public health measure to address the syphilis epidemic. Arch Intern Med 1993;153:1799-1804.","DOI":"10.1001\/archinte.1993.00410150083008"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997;26:1359-1366.","DOI":"10.1093\/ije\/26.6.1359"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Payan C, Roudot-Thoraval F, Marcellin P, Bled N, Duverlie G, Fouchard-Hubert I, Trimoulet P, Couzigou P, Cointe D, Chaput C. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study. J Viral Hepat 2005;12:405-413.","DOI":"10.1111\/j.1365-2893.2005.00605.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 2000;60:122-125.","DOI":"10.1002\/(SICI)1096-9071(200002)60:2<122::AID-JMV3>3.0.CO;2-#"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Savvas SP, Koskinas J, Sinani C, Hadziyannis A, Spanou F, Hadziyannis SJ. Changes in epidemiological patterns of HCV infection and their impact on liver disease over the last 20 years in Greece. J Viral Hepat 2005;12:551-557.","DOI":"10.1111\/j.1365-2893.2005.00614.x"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993;74:661-668.","DOI":"10.1099\/0022-1317-74-4-661"},{"key":"ref17","unstructured":"Bourliere M, Halfon P, Portal I. Treatment of chronic hepatitis C in special groups. Gastroenterol Clin Biol 2002;26 Spec No 2:B238-B247."},{"key":"ref18","unstructured":"de Vries MJ, te Rijdt B, van Nieuwkerk CM. Genotype distribution amongst hepatitis C patients in The Netherlands. Neth J Med 2006;64:109-113."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol 2005;11:4085-4089.","DOI":"10.3748\/wjg.v11.i26.4085"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Massad E, Rozman M, Azevedo RS, Silveira AS, Takey K, Yamamoto YI, Strazza L, Ferreira MM, Burattini MN, Burattini MN. Seroprevalence of HIV, HCV and syphilis in Brazilian prisoners: preponderance of parenteral transmission. Eur J Epidemiol 1999;15:439-445.","DOI":"10.1023\/A:1007523027876"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Taylor A, Goldberg D, Hutchinson S, Cameron S, Gore SM, McMenamin J, Green S, Pithie A, Fox R. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect 2000;40:176-183.","DOI":"10.1053\/jinf.2000.0647"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Bourliere M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustiere C, Perrier H, Jullien M. Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 2002;9:62-70.","DOI":"10.1046\/j.1365-2893.2002.00319.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"McCaw R, Moaven L, Locarnini SA, Bowden DS. Hepatitis C virus genotypes in Australia. J Viral Hepat 1997;4:351-357.","DOI":"10.1046\/j.1365-2893.1997.00060.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995;171:1607-1610.","DOI":"10.1093\/infdis\/171.6.1607"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Greene WK, Cheong MK, Ng V, Yap KW. Prevalence of hepatitis C virus sequence variants in South-East Asia. J Gen Virol 1995;76:211-215.","DOI":"10.1099\/0022-1317-76-1-211"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VG, Arankalle VA. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol 2003;41:5240-5244.","DOI":"10.1128\/JCM.41.11.5240-5244.2003"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 2006;78:1296-1303.","DOI":"10.1002\/jmv.20692"},{"key":"ref28","unstructured":"Balogun MA, Laurichesse H, Ramsay ME, Sellwood J, Westmoreland D, Paver WK, Pugh SF, Zuckerman M, Pillay D, Wreghitt T. Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Commun Dis Public Health 2003;6:34-39."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Dal Molin G, Ansaldi F, Biagi C, D&rsquo;Agaro P, Comar M, Croce L, Tiribelli C, Campello C. Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 2002;68:352-356.","DOI":"10.1002\/jmv.10210"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Kleter B, Brouwer JT, Nevens F, van Doorn LJ, Elewaut A, Versieck J, Michielsen PP, Hautekeete ML, Chamuleau RA, Brenard R. Hepatitis C virus genotypes: epidemiological and clinical associations. Benelux Study Group on Treatment of Chronic Hepatitis C. Liver 1998;18:32-38.","DOI":"10.1111\/j.1600-0676.1998.tb00124.x"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Mutter RC, Grimes RM, Labarthe D. Evidence of intraprison spread of HIV infection. Arch Intern Med 1994;154:793-795.","DOI":"10.1001\/archinte.1994.00420070117013"},{"key":"ref32","unstructured":"Skoretz S, Zaniewski G, Goedhuis NJ. Hepatitis C virus transmission in the prison\/inmate population. Can Commun Dis Rep 2004;30:141-148."},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Muga R, Sanvisens A, Bolao F, Tor J, Santesmases J, Pujol R, Tural C, Langohr K, Rey-Joly C, Munoz A. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend 2006;82 Suppl 1:S29-S33.","DOI":"10.1016\/S0376-8716(06)80005-0"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG. Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature. J Adv Nurs 2001;33:357-370.","DOI":"10.1046\/j.1365-2648.2001.01672.x"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i8\/1237.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:49:35Z","timestamp":1557316175000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i8\/1237.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.1237","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}